Patent Foramen Ovale Closure among Patients with Hypercoagulable States Maintained on Antithrombotic Therapy
Conclusions: Among patients with HCSs maintained on anticoagulant or antiplatelet therapies, PFO closure was associated with a significantly lower risk of CVA or TIA.Cardiology
Source: Cardiology - Category: Cardiology Source Type: research
More News: Accidents | Antiphospholipid Syndrome | Cardiology | Heart | Hughes Syndrome | Patent Foramen Ovale | Stroke | Study